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BAP31 is an endoplasmic reticulum protein-sorting
factor that associates with newly synthesized inte-
gral membrane proteins and controls their fate (i.e.,
egress, retention, survival, or degradation). BAP31
is itself an integral membrane protein and a consti-
tuent of several large protein complexes. Here, we
show that a part of the BAP31 population interacts
with two components of the Sec61 preprotein trans-
locon, Sec61b and TRAM. BAP31 associateswith the
N terminus of one of its newly synthesized client pro-
teins, the DF508 mutant of CFTR, and promotes its
retrotranslocation from the ER and degradation by
the cytoplasmic 26S proteasome system. Depletion
of BAP31 reduces the proteasomal degradation of
DF508 and permits a significant fraction of the surviv-
ing protein to reach the cell surface. Of note, BAP31
also associates physically and functionally with the
Derlin-1 protein disclocation complex in the DF508
degradation pathway. Thus, BAP31 operates at early
steps to deliver newly synthesized CFTRDF508 to its
degradation pathway.
INTRODUCTION
BAP31 is an evolutionarily conserved, ubiquitously expressed
polytopic integral protein of the endoplasmic reticulum (ER)
(Adachi et al., 1996; Kim et al., 1994; Ng et al., 1997), and has
been implicated in the ER sorting of diverse client membrane
proteins. BAP31 is comprised of three membrane-spanning
segments and a 13 kDa cytosolic tail containing an extended
coiled-coil region, which connects BAP31 to the cytoplasmic ac-
tomyosin complex via interaction with a specific isoform of g-ac-
tin (Ducret et al., 2003; Nguyen et al., 2000). In addition, BAP31
has been shown to associate with and promote the vesicular
transport from the ER of MHC class I molecules (Paquet et al.,
2004; Spiliotis et al., 2000), cellubrevin (Annaert et al., 1997),1080 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.and tetraspanins (Stojanovic et al., 2005); of CD11b/CD18 from
secondary granules to the plasma membrane in neutrophils
(Zen et al., 2004); the ER maturation or trafficking of CFTR (Lam-
bert et al., 2001); and the retention of mIgD (Schamel et al.,
2003), cytochrome P450 2C2 (Szczesna-Skorupa and Kemper,
2006), and PTPLB (Wang et al., 2004) at the ER. Of note, al-
though only integral membrane proteins and not luminal proteins
have been detected to date as clients for BAP31-mediated ER
export/retention/degradation, not all newly synthesized integral
membrane proteins depend on BAP31 for sorting. For example,
egress of a5b1 or avb3 integrins to the plasma membrane is not
influenced by deletion of BAP31, whereas components of the
tetraspanin web, CD9 and CD81, that help to organize these in-
tegrins into functional complexes at the cell surface, do require
BAP31 for cell surface expression (Stojanovic et al., 2005).
It is important to reconcile how a protein like BAP31 deter-
mines the fate of client proteins whose ultimate destinies are
so different. One possibility is that BAP31 is a proximal factor
that associates with client proteins and promotes their delivery
to those complexes that determine the fate of the protein in
question. To address this question, we sought to better define
the binding partners of BAP31 in the ER membrane. In addition,
we focused on one client protein, the CFTRmutant CFTRDF508.
CFTRDF508 is delivered to a specific ER membrane complex,
the Derlin-1 complex, which initiates its retrotranslocation from
the ER and subsequent cytoplasmic degradation by the 26S
proteasome (Sun et al., 2006; Younger et al., 2006).
Nascent glycopolypeptides are cotranslationally modified
within the ER at Asn-X-Ser/Thr motifs by the attachment of
a Glc3Man9GlcNAc2 glycan. After removal of two of the glucose
residues, the Glc1Man9GlcNAc2 protein interacts with calnexin
(CNX) and calreticulin (CRT) where it achieves its correct folding.
Release from the chaperones is promoted by further trimming by
glucosidase II and the protein packaged into COPII vesicles for
transport to the Golgi complex for additional processing. Other-
wise, the glycoprotein interacts with CNX/CRT for another round
of folding (Parodi, 2000). If correct folding is not achieved or is
kinetically slow, the protein may be eliminated by retrotransloca-
tion from the ER to the cytoplasm, where it is subject to ubiquitin-
mediated degradation by the proteasome complex, a process
referred to as ER-associated degradation (ERAD) (McCracken
and Brodsky, 1996; Meusser et al., 2005).
The ER luminal protein Yos 9p and the ER membrane protein
Hrd3p can recruit misfolded proteins independently of each
other to the ER membrane ubiquitin ligase Hrd1p for substrate
polyubiquitination (Denic et al., 2006). The ubiquitinated sub-
strates are typically extracted from the membrane by another
ER membrane protein Ubx2p, which recruits a cytosolic ATPase
complex, consisting of p97/VCP in mammals and Cdc48 in
yeast, and a heterodimeric cofactor, containing Ufd1p and
Npl4p. The hydrolysis of ATP is required tomove the polypeptide
into the cytosol so that it can be degraded by the proteasome
(Carvalho et al., 2006; Jarosch et al., 2002; Neuber et al., 2005).
So far, the nature of retrotranslocation channels is less well
understood. It was initially believed that the Sec61 protein-
conducting channel for entry of nascent proteins into the ER also
played a role in retrotranslocation (Kopito, 1997; Tsai and Rapo-
port, 2002). Another protein suggested to forma dislocation chan-
nel in theER is themammalian proteinDerlin-1and its yeast homo-
log Der1p. Both are multispanning membrane proteins that are
required for degradation of certain ERAD substrates, including
CFTRDF508 (Younger et al., 2006). Der1p/Derlin1 associates
with Hrd1p via Usa1p and interacts with the Cdc48/p97 complex
directly or through VIMP (Carvalho et al., 2006; Lilley and Ploegh,
2004; Ye et al., 2004). A recent study employing real-time fluores-
cence detection suggests that Derlin-1 promotes retrotransloca-
tion of a luminal substrate, pro-a factor (Wahlman et al., 2007).
Here, we have employed the split-ubiquitin yeast two-hybrid
screen to detect interactions between integral membrane proteins
(Wanget al., 2003, 2004) and identified two candidate bindingpart-
nersofBAP31,Sec61b, andTRAM,bothofwhichare integralmem-
brane components of the ER Sec61 preprotein translocon (Gorlich
and Rapoport, 1993). BAP31 associates with functional translo-
cons and with the N-terminal multispanning domain 1 (MSD1) of
the BAP31 client protein CFTR independently of the C terminus
and promotes retrotranslocation of CFTRDF508 from ER vesicles
in vitro. Moreover, BAP31 associates physically and functionally
with Derlin-1 to promote the cellular degradation of CFTRDF508.
The findings suggest a model in which BAP31 can access
CFTRDF508 at its site of biogenesis at the Sec61 translocon and
promote its extraction from theERmembrane via theDerlin-1com-
plex, resulting in the cytoplasmic degradation of CFTRDF508.
RESULTS
BAP31 Associates with TRAM and Sec61b
Utilizing BAP31 as bait in the split-ubiquitin yeast 2-hybrid
screen to detect interactions between membrane-associated
proteins (Wang et al., 2004), two constituents of the Sec61 pre-
protein translocon, Sec61b and TRAM, exhibited the highest hit
rate. No Sec61b/TRAM hits were obtained using a control ER
membrane protein as bait. The structure of the BAP31 bait fusion
protein is depicted in Figure S1A available online. Screening con-
ditions had been optimized and validated as described in Figures
S1B and S1C. As illustrated in Figure 1A, the requisite cleavage
and release of PLV by ubiquitin-dependent proteases (UBP) in
this screen depends on the association of the ubiquitin C-termi-
nal fragment (Cub, attached to the bait protein) and the ubiquitinN-terminal fragment (NubG, attached to prey proteins), which is
driven by the interactions between bait and prey proteins. As
shown in Figure 1B, both NubG-TRAM and NubG-Sec61b, but
not NubG alone, promoted such cleavage in the presence of
BAP31-Cub-PLV. Conversely, cleavage was not observed
when a control ER membrane protein was attached to Cub-
PLV (data not shown). Associations between BAP31 and either
Sec61b (Figure 1C, left) or TRAM (Figure 1C, right) were likewise
demonstrated by transient cotransfection of vectors expressing
the epitope-tagged proteins in Cos1 cells, followed by immuno-
precipitation of either the BAP31 protein or the Sec61b and
TRAM proteins. Association was also confirmed by coimmuno-
precipitation of endogenous BAP31 and endogenous Sec61b
in HeLa and KB cells (Figure 1D). Antibodies recognizing
TRAM were unavailable, but specificity was further established
in transiently transfected COS1 cells by demonstrating that
BAP31 associated with full-length TRAM but not with N-terminal
deletion constructs that were expressed at equivalent levels
(Figure 1E). Moreover, TRAM and Sec61b were demonstrated
to colocalize with BAP31 at the ER by conventional fluorescence
microscopy in Cos-1 cells (Figure S2). As documented later in
Figure 7, BAP31 was also found to associate with functional
Sec61 translocons and nascent forms of CFTR and CFTRDF508.
BAP31 Regulates CFTRDF508 Degradation
Todetermine if CFTRandCFTRDF508are potential client proteins
of BAP31, we utilized a baby hamster kidney (BHK) cell line stably
expressing the twoproteins taggedwith theHAepitope (Figure2A,
upperpanel). Asexpected, theDF508 form residedprimarily as the
core glycosylated ‘‘B’’ form in the ER whereas wt CFTR was also
comprised of the more abundant, highly glycosylated ‘‘C’’ form
(Younger et al., 2004). Both CFTR and CFTRDF508 were found
to precipitate with antibody against endogenous BAP31 but not
with preimmune IgG (Figure 2A, lower panel), and immunofluores-
cence microscopy clearly showed that most of the CFTR in these
cells codistributedwith ERBAP31,with the exception of a fraction
at the plasma membrane (Figure S3). The remaining C band after
Endo H digestion (Figure S4) could access some BAP31, consis-
tent with the findings that both BAP31 and the translocon are par-
tially located in the ER-Golgi intermediate compartment (Annaert
et al., 1997; Greenfield and High, 1999). As expected, Sec61b
was also present in the BAP31 immunoprecipitates but, of note,
in the highly expressing CFTR cells, more Sec61b was detected
(lane 5), suggesting that overexpressed CFTR might stimulate
the association between BAP31 and Sec61b.
The consequences of BAP31 siRNA knockdown on both the
expression level andmaturation status of CFTR and CFTRDF508
in these BHK cells are shown in Figure 2B. The nucleotide and
amino acid sequences of BHK BAP31 are reported in Figure S5
(deposited in GenBank, accession number DQ525635). A reduc-
tion in BAP31 caused the levels of both CFTR and CFTRDF508
to increase significantly and, in the case of CFTRDF508, more
heavily glycosylated forms also appeared (Figures 2B and 2C).
This effect was specific since BAP31 knockdown influenced nei-
ther the levels nor the distribution of the resident proteins of the
ER, calnexin and Sec61b, the ER-associated ribosomal protein
L4, or a component of the 26S proteasome, 5a (Figure 2C). This
latter finding also argues that the increase in CFTR andCell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc. 1081
Figure 1. BAP31 Interacts with Sec61b and TRAM
(A) Representation of the split-ubiquitin two-hybrid system. Polypeptides that interact with the bait protein bring together the C-terminal fragment (Cub) and
a modified N-terminal fragment (NubG, isoleucine 13 replaced by glycine) of ubiquitin, allowing ubiquitin-specific proteases (UBPs) to liberate PLV (protein A,
LexA, and VP16) from Cub, which then is free to enter the nucleus and activate transcription of the lacZ and HIS3 reporter genes.
(B) Western blot analysis of yeast L40 cell lines expressing BAP31-Cub-PLV fusion protein with or without coexpression of NubG or NubG-TRAM or NubG-
Sec61b vectors, in the presence or absence of added Cu2+ to activate the Cup1 promoter. Cells were grown to logarithmic phase in relative selection media.
Proteins were extracted and analyzed by immunoblot with rabbit immunoglobulin G (IgG)-horseradish peroxidase (HRP).1082 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.
CFTRDF508 levels was not due to a reduction in proteasome
levels.
The fact that BAP31 siRNA stimulated the acquisition of
higher-order forms of CFTRDF508 suggests that at least some
of these molecules have the potential to reach the cell surface.
To test this, antibody recognition of HA epitopes located at the
cell surface of nonpermeabilized intact cells was assessed in
two independent assays and revealed that knockdown of
BAP31 caused a 5- to 6-fold increase in the amount of HA-
CFTRDF508 at the cell surface, as determined by the signal
derived from Alexa 488-coupled detection of anti-HA antibody
added to cells and assayed in a 96-well plate reader (Figure 2D)
and by FACS analysis (Figure 2E).
Together, these results indicate that BAP31 either restrains the
synthesis or promotes the degradation of CFTRDF508, but they
also suggest that in the BAP31 knockdown cells both the proper
folding and egress out of the ER of at least a fraction of the
CFTRDF508 molecules can take place. BAP31, therefore, con-
tributes to the intracellular retention of CFTRDF508 at the ER.
To elucidate the mechanism of enhanced expression of
CFTRDF508 in response to BAP31 siRNA, [35S]methionine pulse
and pulse-chase labeling of the protein was conducted. No influ-
ence was seen on the rate of DF508 synthesis but the half-life of
newly synthesized DF508 was increased 2-fold (Figures 3A and
3B). In this representative experiment, variation in gel loading
was normalized against a control cellular protein (actin). Thus,
BAP31 contributes to the enhanced degradation of DF508,
which together with potentially other influences of BAP31 on
the retention of DF508 in the ER, accounts in part for the failure
of DF508 to reach the cell surface.
BAP31 Regulates CFTRDF508 Degradation
by Promoting Its Dislocation from the ER
To study the influence of BAP31 on retrotranslocation of
CFTRDF508 from the ER, cell-free translation was conducted
in a rabbit reticulocyte lysate supplemented with [35S]methio-
nine. In the absence of ER vesicles, a negligible amount of
CFTR or CFTRDF508 translation product at the correct size
was observed by SDS PAGE, although aggregated product at
the top of the gel was apparent (Figure 4A). In the presence of
ER vesicles derived from dog pancreas, on the other hand, het-
erogeneous products of the expected size were obtained, which
is consistent with the findings that most of CFTR folding has fin-
ished by the end of its synthesis, implying a largely cotransla-
tional process (Kleizen et al., 2005).
We then investigated the contribution of BAP31 to the release
of full-length CFTRDF508 from these ER microsomes into the
postmicrosomal supermatant. Of note, when translation was
conducted in the presence of antagonizing antibody directed at
the cytoplasmic C-terminal tail of BAP31, a significant increase
was seen in the amount of newly synthesized CFTRDF508 thatwas subsequently recovered with ER vesicles by centrifugation
(Figure 4B, top panel). In contrast, the amount of newly synthe-
sized full-size CFTRDF508 that was recovered in the post-ER su-
pernatantwas reduced (Figure 4B, secondpanel). This effectwas
not seen with the antibody directed against Sec61b. Anti-BAP31
antibody had no effect on the ER and supernatant levels of an un-
related ER membrane translation product p515 (Figure 4B).
Pulse-chase analyses (Figure 4C), in whichmicrosomes contain-
ing [35S]CFTRDF508 were subsequently incubated in fresh, cold
reticulocyte lysate, showed that anti-BAP31 antibody caused re-
tention of more CFTRDF508 in the ER and less in the supernatant
at different time points. In addition, the effects of anti-BAP31
were also assessedon the timecourseofCFTRDF508biosynthe-
sis and release from microsomes. At 20 min, the ER pool of
CFTRDF508 appeared as incompleted translation products, indi-
cating that mature CFTRDF508 had not been produced; there
was no CFTRDF508 detected in the supernatant (Figure 4D).
Importantly, anti-BAP31 antibody had no effect on CFTRDF508
production at this time point. After 40 min translation, however,
anti-BAP31 antibody induced accumulation of more full-length
CFTRDF508 in the ER but less CFTRDF508 in the supernatant
compared to control (Figure 4D). Moreover, 10% FCS had no ef-
fect on the ER activities related to CFTRDF508 (Figure S6A) and
the relative pool of p515 was unaffected by antibody treatment
(Figure S6B). In addition, anti-BAP31 antibody did not affect the
ER levels of CFTRDF508 generated from a truncated mRNA to
generate a translocon-locked translocation intermediate (Krieg
et al., 1989) (Figure 4E),which remained attached to the ribosome
(FigureS7).Collectively, the results show that anti-BAP31caused
an increase in ER-associated CFTRDF508 and a decrease in ER-
derived CFTRDF508 outside the ER, suggesting that BAP31 pro-
motes retrotranslocation of CFTRDF508 from the ER following its
initial synthesis and translocation into the ER.
Another way of antagonizing BAP31 function is to use a domi-
nant-interfering BAP31 that lacks a portion of the BAP31 cyto-
solic tail (and is coincident with the caspase-cleavage product
of BAP31). This construct, p20BAP31, physically associates
with full-length BAP31 (Ng et al., 1997; Nguyen et al., 2000)
and, like BAP31, a fraction of ectopically expressed p20BAP31
was found in association with Sec61b and TRAM (Figures 5A
and5B).Consistentwith the findings usingantagonizing antibody
against BAP31, cotranslation of dominant-interfering p20BAP31
with CFTRDF508 in the presence of dog pancreatic microsomes
caused an increase in the level of ER-associated CFTRDF508
(Figure 5C). This effect of p20BAP31 appears to be specific as
it did not adversely influence the synthesis and ER-dependent
processing of in vitro translated TRAM (Figure 5D).
Thus, two independent manipulations of BAP31 in isolated
ER—antagonizing antibodies and dominant interfering
p20BAP31—suggest that BAP31 plays a role in retrotranslocat-
ing CFTRDF508 from the ER to the cytoplasm.(C) Cos-1 cells were transiently transfected with BAP31-Flag, Myc-Sec61b, and TRAM-HA, individually or together. Immunoprecipitation was performed by
antibodies against Flag, Myc, and HA, then the immunoprecipitates (IP) were analyzed by immunoblot as indicated.
(D) Endogenous BAP31 and Sec61b were coimmunoprecipitated from both HeLa and KB cells (lanes 3 and 6), and compared to precipitates derived using
preimmune IgG (lanes 2 and 5).
(E) BAP31 associates with the N-terminal region of TRAM. BAP31-Flag was cotransfected with various truncated forms of TRAM in Cos-1 cells and the associ-
ations between the two proteins monitored by immunoblotting of anti-HA immuno-precipitates with antibodies against Flag (top panel). The middle and lower
panels show the parallel expressions of the TRAM variants and BAP31, respectively.Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc. 1083
Figure 2. BAP31 Regulates CFTRDF508 Degradation
(A) BAP31 associates with CFTR and CFTRDF508. Baby hamster kidney (BHK) cells, stably expressing the wild-type and DF508 mutant of CFTR, were lysed in
CHAPS buffer. The protein expression levels of CFTR, BAP31, and Sec61b in the lysates were detected by the indicated antibodies (top panel). The associations
between endogenous BAP31, Sec61b, and CFTR were monitored by immunoblotting of anti-BAP31 immunoprecipitates, as indicated. As a control, preimmune
IgG instead of anti-BAP31 antibody was used (bottom panel).
(B) BHK cells stably expressing CFTR or CFTRDF508 were treated with siRNA against hamster BAP31 (single transfection with 50 nM siRNA, lanes 2 and 5; dou-
ble transfection, lanes 3 and 6). Double transfected siRNA against Luciferase (50 nM, siLuc) was used as a control (lanes 1 and 4). The protein expression levels of
CFTR, BAP31, and actin were monitored with the corresponding antibodies.
(C) Knockdown of BAP31 does not affect the levels/distribution of the ER membrane proteins Sec61b and calnexin, the ribosome protein, L4, or the proteasome
protein, 5a. BHK cells stably expressing CFTRDF508-HAwere transfected with siRNA against BAP31 and Luciferase. 20%of the transfected cells were lysed and
monitored as input (T) (lanes 1 and 5), and the remaining cells were homogenized in HEPES-KOH (pH 7.2), 120 mMKAc, 5 mMMgAc2, 1 mMDTT and 5mMATP.
The postnuclear supernatant was centrifuged for 2 min through a 0.75M sucrose cushion at 160, 0003 g and the supernatant fraction (Sup, lanes 4 and 8), the
cushion fraction (M, lanes 3 and 7), and the pellets (ER, lanes 2 and 6) were lysed and analyzed by SDS PAGE and immunoblotting with the relevant antibody.1084 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.
Figure 3. BAP31 Regulates the Rate of CFTRDF508 Degradation
(A) Pulse labeling. BHK cells stably expressing CFTRDF508-HA were transfected with BAP31 or control Luc siRNA. The transfected cells were pulse-labeled with
[35S]methionine for different times, after which CFTRDF508-HA was recovered by immunoprecipitation and subjected to SDS PAGE and autoradiography.
Densitometry of the CFTRDF508-HA bands was normalized to an internal control (actin) and presented as arbitrary units.
(B) Pulse-chase labeling. As in (A), except that cells were incubated for 30minwith medium containing [35S]methionine and then transferred tomedium containing
excess unlabelled methionine, after which relative levels of the normalized radioactive CFTRDF508-HA were determined at the indicated time points.BAP31 Promotes CFTRDF508 Degradation via
the Derlin-1 Protein Dislocation Complex
Derlin-1/Der1p and Hrd1p are integral membrane components
of a recently identified ERAD protein dislocation complex (Car-
valho et al., 2006). Moreover, Derlin-1 interacts with the ubiquitin
E3 ligase RMA1 or the AAA-ATPase p97 to facilitate degradation
of CFTR/ CFTRDF508 via the cytosolic Hsc70/CHIP E3 complex
(Sun et al., 2006; Younger et al., 2006). Since Derlin-1 has been
reported to associate with CFTRDF508 to promote its degrada-
tion, we sought to determine its relationship to BAP31.
Cotransfection of epitope-tagged BAP31, Derlin-1, and RMA1
intoHeLa cells, and analysis by coimmunoprecipitation, revealed
that both Derlin-1 and RMA1 associated with BAP31 (Figure 6A).
Interestingly, Derlin-1 expression levels were considerably lowerthan those of RMA1, yet equivalent amounts of the two proteins
were recovered with BAP31. Relative to RMA1, therefore, bind-
ing of BAP31 to Derlin-1 appears to be more pronounced. Inter-
action was also confirmed by coimmunoprecipitation of endog-
enous BAP31 and Derlin-1 in HEK293 cells (Figure S8).
In contrast to HeLa cells, similar levels of ectopic Derlin-1 and
RMA1 were observed in transfected CFTRDF508-expressing
BHK cells (Figure 6B). As previously reported (Younger et al.,
2006), overexpression of ectopic Derlin-1 promotes CFTRDF508
degradation, and this was also seen in the present study in which
Derlin-1 caused a reduction in CFTRDF508 (Figures 6B, cf. lanes
1 and 3, and 6C). Importantly, treatment of the cells with BAP31
siRNA resulted in an elevation of CFTRDF508 levels, but in
this context Derlin-1 overexpression was without effect on(D) BHK cells stably expressing CFTRDF508-HAwere transfected with BAP31 siRNA or control Luc siRNA. The transfected cells were aliquoted into 96-well black
plates, the intact cells treated with anti-HA followed by secondary antibody conjugated with Alexa-488 green, and the cell surface CFTRDF508-HA signals re-
corded. Shown is the mean and SD of three independent experiments.
(E) Similar to (C), except that cell surface CFTRDF508-HA signals were analyzed by FACS. The signals were gated (M1) to exclude emissions obtained using the
secondary antibody alone.Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc. 1085
Figure 4. BAP31 Regulates CFTRDF508 Retrotranslocation from the ER
(A) CFTR and CFTRDF508 mRNAs were translated in vitro in the presence of [35S]methionine, with or without the dog pancreas ER microsomes, and the radio-
active products resolved by SDS PAGE and autoradiography.
(B) Equal amounts of dog pancreas ER microsomes were incubated with 10% of heat-inactived fetal calf serum for 30 min, then preimmune IgG, anti-BAP31,
anti-Sec61b, or anti-BAP31/Sec61b antibodies were added for another 30 min at room temperature. The membranes were recovered and suspended in equal
volumes of in vitro translationmixtures containing either CFTRDF508mRNA or mRNA encoding themodel ER integral membrane protein p515, and incubated for
40 min at 30C, after which the ER and supernatants (Sup) were recovered by centrifugation. The DF508CFTR and p515 translation products were detected by
autoradiography as in A.
(C) As in (B). After 40 min translation, three units of preimmune treated ER and one unit of anti-BAP31 antibody treated ER were separated, followed by the ad-
dition of fresh rabbit reticulocyte lysate and incubation for different times at 30C. The ER and supernatant were detected by autoradiography and exposed for
equal times.
(D) As in (B), the ER was treated with preimmune sera and anti-BAP31 antibodies. CFTRDF508 mRNA was translated for different times. The ER and supernatant
were analyzed by SDS PAGE and autoradiography.
(E) As in (B), except that CFTRDF508 cDNAwas digested with Hpa 1 in order to transcribe amRNA fragment lacking the stop codon, which upon translation in the
presence of dog pancreas microsomes generates a ribosome-tethered 777 amino acid N-terminal fragment locked within the protein translocon. This truncated
CFTRDF508 comprises MSD1, NBD1, and about half of the R domain 1.1086 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.
Figure 5. Dominant-Negative Form of BAP31, p20, Stabilizes CFTRDF508
(A) HeLa cells were transiently transfected with p20BAP31 or control vector. Anti-Sec61b immunoprecipitates were analyzed by immunoblotting with anti-BAP31
(top panel) or anti-Sec61b (second panel from the top). Equivalent aliquots of total cell lysates were immunoblotted with anti-BAP31 (third panel from the top) or
anti-Sec61b (bottom panel).
(B) Interactions between TRAM and p20BAP31 were monitored in cotransfected cells as indicated.
(C) BAP31 and p20BAP31 mRNAs were translated either alone or cotranslated with CFTR and DF508CFTR mRNA in vitro in the presence of dog pancreas ER
microsomes, after which the microsomes were recovered and the [35S]-labeled products detected by SDS PAGE and autoradiography.
(D) TRAM-HA mRNA was translated in the presence or absence of microsomes either alone or cotranslated with p20BAP31 or BAP31 mRNAs, as indicated.CFTRDF508 (Figures 6B, cf lanes 4 and 6, and 6C). This was
confirmed in a pulse-chase examination of [35S]-labeled
CFTRDF508: BAP31 siRNA reduced the rate of CFTRDF508
degradation in the presence of excess Derlin-1 by about 3.5-
fold (Figure 6D,E). Thus, BAP31 not only physically associates
with Derlin-1, but the two proteins also functionally interact.
Consistent with a role for BAP31 upstream to promote interac-
tion of CFTRDF508 with the Derlin-1 complex, knockdown of
BAP31 caused an increase in CFTRDF508 but the amount of
CFTRDF508 that was recovered by coimmunoprecipitation with
Derlin-1 following BAP31 knockdown was significantly reduced
as a % of total CFTRDF508. As expected, Derlin-1 associated
with significantly less BAP31 in the same immunoprecipitate
(Figure 6F). In addition, treatment of the HEK293 cells stably ex-
pressingCFTRDF508withDerlin-1 siRNA resulted in an elevationof CFTRDF508 levels, and anti-BAP31 immunoprecipitation col-
lected less Derlin-1 butmuchmoreCFTRDF508 compared to the
siLuc control (Figure 6G). Thus, BAP31 could promote Derlin-1-
mediated degradation of CFTRDF508 by promoting the associa-
tion of CFTRDF508 with the Derlin-1 complex or by promoting
retrotranslocation by Derlin-1, or both. It is noteworthy, however,
that interference with the expression of either p97/VCP/cdc48
(Cao et al., 2003) or of Derlin-1 (Taxis et al., 2002) in endothelial
cells leads to the accumulation of large vesicles typically associ-
ated with a protein overload response, which can be reversed by
overexpression of Derlin-1 (Hu et al., 2006). A very similar
morphology was observed in BHK cells treated with BAP31
siRNA but, in this case, this morphology was not reversed by
Derlin-1 overexpression (Figure 6H), again consistent the sug-
gestion that BAP31 functions upstream on the Derlin-1 pathway.Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc. 1087
Figure 6. BAP31 Promotes CFTRDF508 Degradation via the Derlin-1 Protein Dislocation Complex
(A) BAP31 interacts with Derlin1 andRMA1. HeLa cells were transiently transfectedwith vectors encoding BAP31-Flag, HA-Derlin1, andHA-RMA1 individually or together as
indicated.TheabilityofBAP31toassociatewithDerlin1andRMA1wasmonitoredbyimmunoblottingofanti-Flag immunoprecipitateswithantibodiesagainstHAoranti-BAP31.1088 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.
BAP31 Can Associate with CFTRDF508 at an Early Step
in Its Biogenesis
Although BAP31 was found to interact directly with only the
Sec61b and TRAM constituents of the Sec61 translocon in the
yeast split-ubiquitin screen, it would be expected to associate
with Sec61a if BAP31 is capable of complexing with functional
translocons. As shown in Figure 7A, this was confirmed by coim-
munoprecipitation. Moreover, BAP31 was also found to associ-
ate with translocon-locked truncated CFTRDF508 (Figure 7B)
and with a region of CFTR comprising the N-terminal 370 amino
acids independently of the C terminus (Figure 7C), which corre-
sponds to the multispanning domain 1 (MSD1) and is also the
region with which Derlin-1 associates (Younger et al., 2006).
Thus, BAP31 molecules that are in proximity to the Sec61 trans-
locons are well positioned to associate with the newly emerging
N-terminus of CFTRDF508 nascent chains, as a potential prelim-
inary to promoting transfer to the Derlin-1 complex.
DISCUSSION
BAP31 associates with and promotes the ER sorting of multiple
integral membrane proteins whose fate within the cell can be
very different. This has led us to speculate that BAP31 may be
a sorting factor that contributes to the delivery of client proteins
from their site of synthesis to specific ER complexes that medi-
ate subsequent export, retention, degradation, or survival of the
client protein in question. The fact that a fraction of BAP31 is
found constitutively in association with two components of the
Sec61 preprotein translocon, Sec61b and TRAM (Gorlich and
Rapoport, 1993), is consistent with this model.
To examine the elements of this model, we chose to investi-
gate the role of BAP31 in mediating the degradation of the hy-
per-unstable mutant of CFTR, CFTRDF508, which is the major
causative defect in the underlying etiology of cystic fibrosis. A
better understanding of the proximal pathway leading to ER dis-
location and subsequent degradation of CFTRDF508 by the
cytoplasmic 26S proteasome systemmay help to uncover drug-
able targets for therapeutic resolution of the disease. Cystic
fibrosis results from the failure of the functional but ER-retained
CFTRDF508 to reach the cell surface rather than by a defect in
protein function. Indeed, we (this study) and others (Lambert
et al., 2001) have found that reducing the expression of BAP31
in cells resulted in a significant fraction of CFTRDF508 reachingthe cell surface. Although we did not map in detail the regions of
CFTR that associatewithBAP31,wedid find thatBAP31 is ideally
positioned at functional protein translocons in order to associate
with the N-terminal region of CFTR as either the nascent chain or
the newly completed polypeptide emerges from the translocon. It
is not presently known if this association is direct or indirect, and if
it involves multimeric complexes containing BAP31.
Although the distal elements of ERAD that occur on the cyto-
plasmic side of the membrane have been known for some time
(i.e., polyubiquitination of the malfolded protein substrate by E2
ubiquitin-conjugating enzymes and E3 ligases when at least
part of the substrate is exposed to the cytoplasm, followed by
breakdown of the modified substrate by the 26S proteasome)
the critical step of dislocating the substrate across the ER mem-
brane, from the lumen to the cytoplasm, has until recently been
less well understood. In part, the dislocation pathway is dictated
by the location of the folding defect within the protein substrate:
membrane and soluble proteins with folding lesions on the lumi-
nal side are targeted to ERAD-L dislocation machinery, whereas
membrane proteins with defects in cytoplasmic domains are
extracted from themembranevia theERAD-Ccomplex (Carvalho
et al., 2006). Interestingly, the involvement of Derlin-1, a mem-
brane-integral constituent of the L complex, has previously
been shown to be important in the CFTRDF508 degradation
pathway, despite the fact that theDF508 folding defect lies within
nucleotide binding domain 1 (NBDI) of the protein on the cyto-
plasmic side of the membrane. This likely reflects the fact that
DF508 also causes defects in the assembly of MSD1 and MSDII
in the CFTR protein (Chen et al., 2004). Derlin-1 has been pro-
posed to interact with MSD1 of CFTRDF508 and to physically
link CFTRDF508 to the downstream E3 ubiquitin ligase complex
comprised of the RING domain protein RMA1/RNF5 and Ubc6e,
which scans defects at folding steps prior to NBDII synthesis and
is defective in CFTRDF508 (Younger et al., 2006). A second E3
complex, comprised of Hsc70 and CHIP, detects defects in the
terminal stages of CFTR folding (Meacham et al., 2001).
Several lines of evidence indicate that BAP31 operates proxi-
mal to or at the Derlin-1 dislocation complex on the CFTR degra-
dation pathway. Antagonizing antibody directed against the
cytosolic tail of BAP31, for example, caused a selective increase
in ER associated CFTRDF508 following translation in vitro in the
presence of dog pancreatic microsomes, by preventing retro-
translocation to the supernatant. Likewise, cotranslation with(B) Knockdown of BAP31 blocks the degradation of CFTRDF508 induced by overexpression of Derlin1. The siRNA transfected BHK cells, stably expressing
CFTRDF508, were transiently transfected with vectors encoding HA-Derlin1 and HA-RMA1. Cell lysates were immunoblotted with antibodies against CFTR,
HA, BAP31, or actin, as indicated.
(C) The CFTRDF508 immunoblot signals in (B) were quantified by densitometry and normalized to those of the actin input control (B). Shown is the mean and SD
of three independent experiments.
(D) Pulse-chase labeling. BHK cells stably expressing CFTRDF508-HA were transfected with BAP31 or control Luc siRNA. After 48 hr, the cells were further
transfected with control vector or vector expressing Derlin-1. The transfected cells were pulse-labeled with [35S]methionine for 30 min, and then transferred
to medium containing excess unlabelled methionine for different times, after which CFTRDF508-HA was recovered by immunoprecipitation, and subjected
to SDS PAGE and autoradiography. The lysates were immunoblotted with the indicated antibodies.
(E) Densitometry of the CFTRDF508-HA bands in (D) was performed and normalized to an internal control (actin).
(F) BHK cells stably expressing CFTRDF508 were transfected with siRNA against BAP31 or control Luc, and after 48 hr, the cells were transfected with vector en-
codingHA-Derlin1. The association ofHA-Derlin1withCFTRDF508wasmonitoredby immunoblotting of anti-HA immunoprecipitateswith antibody against CFTR.
(G) HEK293 cells stably expressing CFTRDF508 were transfected with Derlin-1 siRNA or control Luc siRNA, and after 48 hr, the cells were collected. The
association of BAP31 with CFTRDF508 was monitored by immunoblotting of anti-BAP31 immunoprecipitates with antibody against CFTR.
(H) Electronmicroscopy. BHKcells were transfectedwith siRNAagainst BAP31 and control Luc. After 48 hr, the cells were transfectedwith control vector or vector
expressing HA-Derli-1 for 24 hr, and the cells visualized by transmission electron microscopy. Representative images are shown.Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc. 1089
a dominant-negative form of BAP31 also resulted in increased
levels of ER-associated translation product. Both lines of evi-
dence argue that BAP31 promotes dislocation of newly synthe-
sized full-length CFTRDF508 back across the ER membrane to
the cytoplasm. In intact cells, BAP31 siRNA retarded the rate of
CFTRDF508 degradation and caused an elevation of CFTRDF508
levels. Moreover, in BAP31-deficient cells, overexpression of
Derlin-1 no longer increased the rate of CFTRDF508 degradation
and theamountofCFTRDF508 that associatedwithDerlin-1 com-
plex was reduced as a % of total. Conversely, knockdown of
Derlin-1 led to an increase in the association of CFTRDF508 with
BAP31. These findings, together with the fact that BAP31 is able
to associate with nascent CFTRDF508 at the same domain that
binds Derlin-1 (Younger et al., 2006), and that BAP31 also physi-
cally associates with Derlin-1, is best explained by a model in
which BAP31 may escort the delivery of CFTRDF508 to the
Derlin-1dislocation complex. This upstream role forBAP31 is con-
sistentwith thefinding thatDerlin-1overexpressiondidnot reverse
the morphological changes associates with BAP31 knockdown.
However, it is also possible that BAP31 can contribute to the ex-
traction of CFTRDF508 by the Derlin-1 complex. Loss of the
Figure 7. BAP31 Associates with Functional
Translocons
(A) Sec61a associates with BAP31. HeLa cells
were lysed in CHAPS buffer, and anti- Sec61a
immunoprecipates were blotted with antibodies
against Sec61a, BAP31 and Sec61b.
(B) The translocon-locked [35S]-labeled truncated
CFTRDF508 translation product was generated
in association with dog pancreas microsomes in
vitro, and subjected to immunoprecipitation
with anti-BAP31 or preimmune IgG. Lysate and
immunopreciptates were monitored by autoradi-
ography or immunoblot, as indicated.
(C) BAP31 associates with the MSD1 domain of
CFTR. HeLa cells were transfected with vectors
expressing CFTR-HA, CFTR-N640-HA (MSD1-
NBD1) and CFTR-N370-HA (MSD1). The ability
of BAP31 to associate with these CFTR fragments
was monitored by immunoblotting of anti-BAP31
immunoprecipitates with antibodies against HA
or BAP31 (left). Cell lysates were immunoblotted
with the indicated antibodies (right).
BAP31 function, e.g., as the resultof siRNA
knockdown, would allow CFTRDF508 to
bypass Derlin-1 and follow a default path-
way to the plasma membrane, which is
consistent with our observations.
ATPase p97 acts to pull unfolded pro-
tein out of the ER membrane (Ye et al.,
2005, 2004). However, only a 50% de-
crease in the degradation of CFTR was
observed in the complete absence of
p97 (Carlson et al., 2006). The fact
that the cytosolic E3 ligaseCHIP can regu-
late CFTRDF508 degradation (Meacham
et al., 2001) suggests that some
CFTRDF508 molecules do not have to
dislocate from the Hrd1p E3 ligase channel. Thus, CFTRDF508
may dislocate by more than one pathway.
In the case of CFTRD508, over 99% of newly synthesized
polypeptides are degraded before being folded (Ward and Ko-
pito, 1994), and some newly synthesized polypeptides can be-
come mature and reach the plasma membrane if they are not
dislocated from the ER for degradation. Thus, the newly synthe-
sized polypeptides may be similar to the unfolded forms of
CFTRD508, which can be recognized by BAP31 or other factors
and delivered to the Derlin-1 dislocation complex.
We envision two possible pathways by which BAP31 might
regulate the degradation of CFTRDF508. Newly synthesized
CFTRDF508, either before entering protein folding cycles (1) or de-
rived from nonproductive folding cycles (2), may be recognized as
an unfolded form, and BAP31 may promote its delivery to the
Derlin-1 complex for degradation. In all cases, ubiquitination of the
dislocated CFTRDF508 results in degradation by the proteasome.
Finally, the proposal that BAP31 promotes degradation of
CFTRDF508 via the Derlin-1 complex suggests a therapeutic
opportunity for the treatment of cystic fibrosis. If CFTRDF508
can be forced to bypass the Derlin-1 complex by a small1090 Cell 133, 1080–1092, June 13, 2008 ª2008 Elsevier Inc.
molecule that either disrupts BAP31-CFTRDF508 or BAP31-Der-
lin-1 associations, transport of CFTRDF508 to the cell surface
might occur, analogous to that obtained as a result of BAP31
reduction by siRNA.
EXPERIMENTAL PROCEDURES
Materials
Antibodies: chicken or rabbit anti-humanBAP31 has been described (Ng et al.,
1997); calnexin monoclonal antibody was from BD Biosciences (Mississauga,
ON,Canada); anti-FLAGM2monoclonal antibody fromSigma; anti-hemagglu-
tinin (HA) 12CA5monoclonal antibody fromBabco (Richmond, CA); anti-c-myc
monoclonal antibody (9E10) from BABCO; rabbit HRP-IgG from ICN Pharma-
ceuticals; mouse anti-CFTR monoclonal antibody M3A7, L12B4 from Chemi-
con; rabbit anti-Sec61b antibody from Upstate; and anti-Derlin-1 antibody
from Sigma. Anti-Sec61a antibody was kindly supplied by Dr. Kurt Dejgaard.
Dog pancreatic rough microsomal membranes were prepared and treated
with EDTA/nuclease as described (Walter and Blobel, 1983). Rabbit reticulo-
cyte lysate (RRL) was from Promega. L-[35S]methionine 10 mCi/mi was from
Amersham. The split-ubiquitin two-hybrid cDNA Libraries have been
described previously (Wang et al., 2004).
Construction of Plasmids
The full-length human TRAM and Sec61 b cDNAs were identified by two-hy-
brid in this study and ligated to pcDNA3.1 vector with HA or Myc tags by
PCR. cDNAs encoding various N-terminus truncated forms of TRAM-HA,
(D1–120)TRAM-HA, (D1–180)TRAM-HA and (D1–240)TRAM-HA) were created
by PCR. BAP31 and its dominant negative form p20 constructs have been
described previously (Wang et al., 2003). HA-derlin1 and HA-RMA1 cDNAs
were derived from HeLa cell RNA, and ligated into pcDNA3.1 vectors. All
new plasmid constructs were verified by sequencing.
Cell Culture and Transfection
Cos-1, KB, and HeLa cells were maintained in minimum essential medium
supplemented with 10% fetal calf serum and 1% penicillin/streptomycin, at
37C in humidified 5% CO2. Baby hamster kidney (BHK) cells stably express-
ing CFTR, CFTR-HA, CFTRDF508, or CFTRDF508-HA were selected using
methotrexate in D-MEM/F-12 medium and normal conditions. Cells were tran-
siently transfected using lipofectAMINE plus (GIBCO BRL) following the man-
ufacturer’s protocols. siRNA transfections were performed using the Smart
Pools of siRNAs from Dharmacon at a final concentration of 50 nM, and the
cells collected at the 72 hr time point.
Immunoprecipitations and Immunoblots
Yeast cells were lysed in 50 ml 1.85 M NaOH per 3 OD546 units and incubated
on ice for 10min. The same volume of 50% trichloroacetic acid was added and
proteins were precipitated by centrifugation for 5 min. The pellet was sus-
pended in 50 ml of SDS sample buffer containing 8 M urea and combined
with 20 ml of 1 M Tris-base for 1.5h at 37C. Eukaryotic cells were lysed in
buffer containing 1% CHAPS, 150 mM NaCl, 50 mM Tris-HCl (pH 7.3), 1 mM
phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 1 mg/ml
pepstain. Lysates were assayed for protein content using the Bio-Rad re-
agent. For immunoprecipitations, after preclearing for 30 min. with protein G
Sepherose (Pharmacia), lysates were incubated with antibodies for 90 min.
at 4C. Immune complexes bound to protein G Sepharose were recovered
in a microfuge and washed four times with lysis buffer and eluted in SDS
sample buffer. All samples were analyzed by SDS PAGE and immunoblotting,
employing standard methodology.
Cell Fractionation
BHK cells stably expressing CFTR or DF508CFTR were transfected with
BAP31 and p20 for the indicated times, harvested, and suspended in HIM
buffer (200 mM mannitol, 70 mM sucrose, 10 mM HEPES, [pH 7.4], 1 mM
EGTA) with or without proteasome inhibitor MG132. Cells were broken with
30 strokes in a motorized Teflon-glass homogenizer operating at 2000 rpm
and the homogenate was centrifuged at 10003 g for 10 min to remove nucleiand cell debris. The supernatant was centrifuged at 90003 g for 10 min to re-
move mitochondria. The supernatant was centrifuged at 170,0003 g to give
a cytosolic supernatant and light membrane ER-enriched pellet.
In Vitro Transcription and Translation
mRNAs encoding CFTR, CFTRDF508, BAP31, p20, and TRAM-HA were syn-
thesized by transcription of cDNAs using T7 RNA polymerase, whereas p515
cDNA (gift from Arthur E. Johnson) was transcribed using SP6 polymerase.
Translation of the transcripts was carried out in the rabbit reticulocyte lysate
system (Promega), supplemented with [35S]methionine, following the manu-
facturer’s protocol for cotranslational processing using canine pancreatic mi-
crosomal membranes. In certain instances, equal amount of the dog pancreas
microsomeswere preblockedwith 10%heat-inactivated fetal calf serum for 30
min, then the preimmune serum, anti-BAP31, anti-Sec61b and anti-BAP31/
Sec61b antibodies were added for another 30 min at room temperature. Equal
amounts of the in vitro translation mixtures including targeted mRNAs were
then used to resuspend the antibody-treatedmicrosome pellets and incubated
for 40 min at 30C. In most cases, the translation mixtures were separated into
microsome pellets and supernatants before analysis by SDS-PAGE.
Flow Cytometry and Plate Assay
BHK cells stably expressing CFTRDF508-HA (triple HA tag located in the
extra-cellular R loop) were transfected with siRNA against BAP31 or luciferase
(control). The transfected cells were stained with anti-HA and the Alexa 488
green signal conjugated second antibody. The cell surface CFTRDF508-HA
signals were analyzed by flow cytometrywith a BectonDickinson FACSCalibur
system. Alternatively, the transfected cells were aliquoted into 96-well black
plates, followed by staining with anti-HA and the secondary antibody conju-
gated with Alexa 488. Cell surface CFTRDF508-HA signals were measured
with the Molecular Devices Analyst HT.
SUPPLEMENTAL DATA
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